Adami, Giovanni
Rossini, Maurizio
Gatti, Davide
Serpi, Paolo
Fabrizio, Christian
Lovato, Roberto
Article History
Received: 7 December 2023
Accepted: 11 March 2024
First Online: 22 March 2024
Competing interests
: Giovanni Adami has received advisory board honoraria, consultancy fees and/or speaker fees from Theramex, UCB, Lilly, Galapagos, Fresenius Kabi, Amgen, BMS, Abiogen and Pfizer. Davide Gatti has received advisory board honoraria, consultancy fees and/or speaker fees from Abiogen, Celgene, Eli-Lilly, Neopharmed-Gentili, Pfizer, UCB. Maurizio Rossini reports advisory board honoraria, consultancy fees and/or speaker fees from AbbVie, BMS, Eli-Lilly, Galapagos, Menarini, Sandoz, Theramex, UCB, outside the submitted work. Paolo Serpi, Roberto Lovato and Christian Fabrizio have not competing interests.